United States Biotechnology & Medical Research

LAVA Therapeutics NV (LVTX)

Track

Track

LAVA Therapeutics NV experienced significant divestment activity throughout September and October 2025. Major institutional shareholders, specifically Cooperatieve Gilde Healthcare IV U.A. and Versant Venture Capital VI, L.P., executed multiple sell orders. These transactions concluded on October 17, 2025, representing the most recent insider trading recorded for the firm.
Ticker: LVTX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for LAVA Therapeutics NV. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.3
Novo Holdings A/S 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
2.60
Quantity 670,558
Value US$1,743,451
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-20 2025-10-17 S Sale
2.2
Cooperatieve Gilde Healthcare IV U.A.
Large shareholder
46,893 -11.9%
406.96
US$4,322,312 		46,893 -11.9% 406.96 US$4,322,312
2025-10-20 2025-10-16 S Sale
2.2
Cooperatieve Gilde Healthcare IV U.A.
Large shareholder
61,339 -21.1%
38.25
US$3,476,501 		61,339 -21.1% 38.25 US$3,476,501
2025-10-15 2025-10-14 S Sale
2.2
Cooperatieve Gilde Healthcare IV U.A.
Large shareholder
11,206 +10.0%
405.86
US$1,404,078 		11,206 +10.0% 405.86 US$1,404,078
2025-10-15 2025-10-13 S Sale
2.2
Cooperatieve Gilde Healthcare IV U.A.
Large shareholder
47,686 -0.9%
1.54
US$73,436 		47,686 -0.9% 1.54 US$73,436
2025-10-10 2025-10-10 S Sale
2.2
Cooperatieve Gilde Healthcare IV U.A.
Large shareholder
49,869 -0.9%
1.55
US$77,297 		49,869 -0.9% 1.55 US$77,297
2025-10-10 2025-10-09 S Sale
2.2
Cooperatieve Gilde Healthcare IV U.A.
Large shareholder
48,169 -0.9%
1.56
US$75,144 		48,169 -0.9% 1.56 US$75,144
2025-10-10 2025-10-08 S Sale
2.2
Cooperatieve Gilde Healthcare IV U.A.
Large shareholder
28,954 -0.5%
1.57
US$45,458 		28,954 -0.5% 1.57 US$45,458
2025-09-23 2025-09-19 S Sale
3.5
Versant Venture Capital VI, L.P.
Large shareholder
532,870 -100.0%
1.40
US$746,764 		532,870 -100.0% 1.40 US$746,764
2025-09-23 2025-09-19 S Sale
3.5
Versant Venture Capital VI, L.P.
Large shareholder
2,370,533 -100.0%
1.40
US$3,322,065 		2,370,533 -100.0% 1.40 US$3,322,065
2025-09-18 2025-09-18 S Sale
3.5
Versant Venture Capital VI, L.P.
Large shareholder
228,791 -30.0%
1.44
US$329,871 		228,791 -30.0% 1.44 US$329,871
2025-09-18 2025-09-18 S Sale
3.5
Versant Venture Capital VI, L.P.
Large shareholder
366,111 -13.4%
1.44
US$527,859 		366,111 -13.4% 1.44 US$527,859
2025-09-18 2025-09-17 S Sale
3.5
Versant Venture Capital VI, L.P.
Large shareholder
226,726 -22.9%
1.49
US$337,640 		226,726 -22.9% 1.49 US$337,640
2025-09-18 2025-09-17 S Sale
3.5
Versant Venture Capital VI, L.P.
Large shareholder
362,806 -11.7%
1.49
US$540,291 		362,806 -11.7% 1.49 US$540,291
2025-09-18 2025-09-16 S Sale
3.5
Versant Venture Capital VI, L.P.
Large shareholder
192,293 -16.3%
1.53
US$294,824 		192,293 -16.3% 1.53 US$294,824
2025-09-18 2025-09-16 S Sale
3.5
Versant Venture Capital VI, L.P.
Large shareholder
307,707 -9.0%
1.53
US$471,776 		307,707 -9.0% 1.53 US$471,776
2023-06-05 2023-06-05 PrS Proposed sale
2.3
Novo Holdings A/S

10% Stockholder

Large shareholder
670,558
2.60
US$1,743,451 		670,558 2.60 US$1,743,451
2025-10-20 2015-10-20 S Sale
2.2
Cooperatieve Gilde Healthcare IV U.A.
Large shareholder
1,000,000 -33.9%
1.46
US$1,460,000 		1,000,000 -33.9% 1.46 US$1,460,000
2025-10-15 2015-10-15 S Sale
2.2
Cooperatieve Gilde Healthcare IV U.A.
Large shareholder
200,000 -4.0%
1.51
US$302,000 		200,000 -4.0% 1.51 US$302,000
Explore more

More insider trading research around LAVA Therapeutics NV

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America